Dr. Patrick Reynolds, MD

NPI: 1508958588
Total Payments
$4,331
2020 Payments
$4,035
Companies
7
Transactions
16

Payment Breakdown by Category

Consulting$2,905 (67.1%)
Research$1,130 (26.1%)
Food & Beverage$280.62 (6.5%)
Other$14.99 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $2,905 1 67.1%
Unspecified $1,130 1 26.1%
Food and Beverage $280.62 13 6.5%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $14.99 1 0.3%

Payments by Type

General
$3,201
15 transactions
Research
$1,130
1 transactions

Top Paying Companies

Company Total Records Latest Year
Ipsen Biopharmaceuticals, Inc $2,919 2 $0 (2020)
United Therapeutics Corporation $1,224 3 $0 (2020)
JAZZ PHARMACEUTICALS INC. $91.08 5 $0 (2019)
Shire North American Group Inc $41.42 3 $0 (2017)
Spectrum Pharmaceuticals Inc. $23.02 1 $0 (2018)
Bayer HealthCare Pharmaceuticals Inc. $17.40 1 $0 (2019)
Mylan Pharmaceuticals Inc. $14.99 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2020 $4,035 2 Ipsen Biopharmaceuticals, Inc ($2,905)
2019 $35.11 2 JAZZ PHARMACEUTICALS INC. ($17.71)
2018 $88.78 4 United Therapeutics Corporation ($30.70)
2017 $171.72 8 United Therapeutics Corporation ($63.35)

All Payment Transactions

16 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/29/2020 United Therapeutics Corporation Cash or cash equivalent $1,130.00 Research
05/20/2020 Ipsen Biopharmaceuticals, Inc ONIVYDE (Drug) Consulting Fee Cash or cash equivalent $2,905.00 General
Category: Oncology
03/20/2019 Bayer HealthCare Pharmaceuticals Inc. Vitrakvi (Drug) Food and Beverage In-kind items and services $17.40 General
Category: Oncology
02/12/2019 JAZZ PHARMACEUTICALS INC. ERWINAZE (Drug) Food and Beverage In-kind items and services $17.71 General
Category: ONCOLOGY
08/14/2018 Jazz Pharmaceuticals Inc. Defitelio (Drug) Food and Beverage In-kind items and services $20.07 General
Category: Hematology
07/18/2018 Mylan Pharmaceuticals Inc. Amnesteem (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $14.99 General
Category: Dermatology
05/10/2018 United Therapeutics Corporation UNITUXIN (Drug) Food and Beverage In-kind items and services $30.70 General
Category: UNITUXIN
04/23/2018 Spectrum Pharmaceuticals Inc. Folotyn (Drug) Food and Beverage In-kind items and services $23.02 General
Category: Oncology
10/03/2017 Jazz Pharmaceuticals Inc. Erwinaze (Drug) Food and Beverage In-kind items and services $18.06 General
Category: Oncology
08/08/2017 Jazz Pharmaceuticals Inc. Erwinaze (Drug) Food and Beverage In-kind items and services $15.88 General
Category: Oncology
06/13/2017 Jazz Pharmaceuticals Inc. Erwinaze (Drug) Food and Beverage In-kind items and services $19.36 General
Category: Oncology
05/24/2017 Ipsen Biopharmaceuticals, Inc Somatuline Depot 120mg-.5ml (Drug) Food and Beverage In-kind items and services $13.65 General
Category: Oncology/Endocrinology
04/11/2017 Shire North American Group Inc ONCASPAR (Biological) Food and Beverage In-kind items and services $15.06 General
Category: ONCOLOGY
04/03/2017 United Therapeutics Corporation UNITUXIN (Drug) Food and Beverage In-kind items and services $63.35 General
Category: UNITUXIN
03/14/2017 Shire North American Group Inc ONCASPAR (Biological) Food and Beverage In-kind items and services $12.19 General
Category: ONCOLOGY
02/14/2017 Shire North American Group Inc ONCASPAR (Biological) Food and Beverage In-kind items and services $14.17 General
Category: ONCOLOGY

About Dr. Patrick Reynolds, MD

Dr. Patrick Reynolds, MD is a Pediatric Hematology-Oncology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508958588.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Reynolds, MD has received a total of $4,331 in payments from pharmaceutical and medical device companies, with $4,035 received in 2020. These payments were reported across 16 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($2,905).

Practice Information

  • Specialty Pediatric Hematology-Oncology
  • Location Los Angeles, CA
  • Active Since 09/28/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 2080P0207X
  • Entity Type Individual
  • NPI Number 1508958588

Products in Payments

  • ONIVYDE (Drug) $2,905
  • UNITUXIN (Drug) $94.05
  • Erwinaze (Drug) $53.30
  • ONCASPAR (Biological) $41.42
  • Folotyn (Drug) $23.02
  • Defitelio (Drug) $20.07
  • ERWINAZE (Drug) $17.71
  • Vitrakvi (Drug) $17.40
  • Amnesteem (Drug) $14.99
  • Somatuline Depot 120mg-.5ml (Drug) $13.65

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Hematology-Oncology Doctors in Los Angeles